These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immunoadsorption therapy for a child with Guillain-Barre syndrome subsequent to Mycoplasma infection: a case study. Arakawa H; Yuhara Y; Todokoro M; Kato M; Mochizuki H; Tokuyama K; Kunimoto F; Morikawa A Brain Dev; 2005 Sep; 27(6):431-3. PubMed ID: 16122631 [TBL] [Abstract][Full Text] [Related]
3. Clinical features in Guillain-Barré syndrome with anti-Gal-C antibody. Samukawa M; Hamada Y; Kuwahara M; Takada K; Hirano M; Mitsui Y; Sonoo M; Kusunoki S; J Neurol Sci; 2014 Feb; 337(1-2):55-60. PubMed ID: 24289889 [TBL] [Abstract][Full Text] [Related]
4. [A case of pharyngeal-cervical-brachial variant of Guillain-Barré syndrome with positive anti-galactocerebroside (Gal-C) IgM antibody]. Kasuya J; Miyazono T; Takenaga S; Arimura K; Osame M; Kusunoki S Rinsho Shinkeigaku; 1999 May; 39(5):538-41. PubMed ID: 10424145 [TBL] [Abstract][Full Text] [Related]
5. Anti-Gal-C antibodies in GBS subsequent to mycoplasma infection: evidence of molecular mimicry. Kusunoki S; Shiina M; Kanazawa I Neurology; 2001 Aug; 57(4):736-8. PubMed ID: 11524496 [TBL] [Abstract][Full Text] [Related]
6. [Effector mechanisms of PNS demyelination in Gal-C induced-EAN]. Saida K Rinsho Shinkeigaku; 1990 Dec; 30(12):1361-3. PubMed ID: 2129197 [TBL] [Abstract][Full Text] [Related]
7. Characterization of the neurological diseases associated with Mycoplasma pneumoniae infection and anti-glycolipid antibodies. Kuwahara M; Samukawa M; Ikeda T; Morikawa M; Ueno R; Hamada Y; Kusunoki S J Neurol; 2017 Mar; 264(3):467-475. PubMed ID: 28025664 [TBL] [Abstract][Full Text] [Related]